ERJ Open Res. 2023 Jul 31;9(4):00158-2023. doi: 10.1183/23120541.00158-2023. eCollection 2023 Jul.
ABSTRACT
Direct healthcare costs for patients with asthma are less than half (-52%) and for patients with COPD are 41% higher if compared to those of patients with bronchiectasis. The leading expense items in bronchiectasis are hospitalisations and antibiotics. https://bit.ly/3Iq8AUP.
PMID:37529638 | PMC:PMC10388176 | DOI:10.1183/23120541.00158-2023
